Point72 Asia (Singapore) Pte. Ltd. Emergent Bio Solutions Inc. Transaction History

Point72 Asia (Singapore) Pte. Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.72 - $11.97 $264,880 - $410,702	34,311 Added 408.42%	42,712 $408 Million
Q3 2024 Nov 14, 2024	SELL	$5.72 - $14.77 $358,512 - $925,739	-62,677 Reduced 88.18%	8,401 $70.2 Million
Q2 2024 Aug 14, 2024	BUY	$1.86 - $6.98 $132,205 - $496,124	71,078 New	71,078 $485 Million
Q4 2023 Feb 14, 2024	BUY	$1.82 - $3.16 $10,920 - $18,960	6,000 New	6,000 $14.4 Million

191

41.3M

899K

256K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $504M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.